|
|
Article: CHINA BIOPHARMACEUTICALS' GROSS PROFIT INCREASES 102%.
- Article from:
- Biotech Financial Reports
- Article date:
- January 1, 2008
CopyrightCOPYRIGHT 2008 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
China Biopharmaceuticals Holdings, Inc. (BULLETIN BOARD: CHBP) , a leading Chinese pharmaceutical company focused on the development, manufacturing and marketing of innovative drugs in China, has announced its results for the third quarter ended September 30, 2007.
Revenue for the three months ended September 30, 2007 increased 65% to $8.6 million compared to $5.2 million for the period ended September 30, 2006. The increase in revenues was attributable to the revenue growth of the company's subsidiary Eyre Pharmaceutical Limited Company (''Erye''). Additionally, the company did not realize quarterly revenue from Shenyang Enshi Pharmaceutical Limited Company ...
Related newspaper, magazine, and journal articles:
|